Arbor Pharmaceuticals Inc. recalls Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes, 2 inner cartons per outer
Arbor Pharmaceuticals recalls Nymalize oral solution (60 mg/20 mL) due to subpotent drug levels. This may not provide intended treatment. Contact for return instructions.
Lower-risk recall
Subpotent Drug
Contact the company & request your remedy
What happened, in plain English
Arbor Pharmaceuticals is recalling Nymalize oral solution because it may contain less active drug than labeled. This could lead to ineffective treatment for patients using it for stroke recovery. Read more at govinfonow.com/recall/36775-arbor-pharmaceuticals-nymalize-oral-solution-recall-subpotent-drug-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/36775-arbor-pharmaceuticals-nymalize-oral-solution-recall-subpotent-drug-risk · Updated October 4, 2026 · FDA enforcement record: FDA #D-1625-2020
Cite this page
“Arbor Pharmaceuticals Nymalize oral solution recall: Subpotent drug risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36775-arbor-pharmaceuticals-nymalize-oral-solution-recall-subpotent-drug-risk. Based on FDA recall #D-1625-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1625-2020%22&limit=1).
Why it’s dangerous
The medication may have lower-than-stated drug concentration, meaning it might not work as intended. This could result in inadequate treatment for conditions like stroke recovery. The risk is not immediate harm but potential treatment failure.
Who’s affected
Patients prescribed Nymalize for stroke recovery or other conditions. Those using the product as directed are most at risk of ineffective treatment.
How to tell if you have this one
Look for Nymalize oral solution (60 mg/20 mL) with 12 unit-dose cups and 12 oral syringes in 2 inner cartons per outer carton. The product was distributed by Arbor Atlanta, GA, with NDC 24338-200-12 and lot number 356884 (expiring 11/30/2021).
- Brand
Arbor Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Verify the product contains 12 unit-dose cups and 12 oral syringes in 2 inner cartons per outer carton with NDC 24338-200-12.
Questions people ask
Is this product dangerous?
The recall is for subpotent drug levels, meaning it may not provide the intended treatment. It is not immediately dangerous but could lead to ineffective therapy.
What should I do if I have this product?
The recall does not specify a remedy, so contact Arbor Pharmaceuticals for instructions on returning the product.
How can I tell if I have the recalled product?
Look for Nymalize oral solution (60 mg/20 mL) with 12 unit-dose cups and 12 oral syringes in 2 inner cartons per outer carton, NDC 24338-200-12, lot 356884 (expiring 11/30/2021).
Contact Arbor Pharmaceuticals
We’ve drafted a message you can send Arbor Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1625-2020 — Arbor Pharmaceuticals Arbor Pharmaceuticals Hello, I own a Arbor Pharmaceuticals that is covered by recall D-1625-2020 from Arbor Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1625-2020 (September 16, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1625-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.